Aberrant P-cadherin expression: Is it associated with estrogen-independent growth in breast cancer?

Pathology Research and Practice

Volumn 198, Issue 12, 2002, Pages 795-801

  Paredes, Joana ^a   Milanezi, Fernanda ^a   Reis Filho, Jorge Sergio ^a   Leitão, Dina ^a,b   Athanazio, Daniel ^c   Schmitt, Fernando ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c Hospital Professor Edgar Santos   (Brazil)

Author keywords

Ductal carcinoma in situ; Estrogen receptor; Invasive breast carcinoma; P cadherin

Indexed keywords

BIOLOGICAL MARKER; CADHERIN; ESTROGEN RECEPTOR; ONCOPROTEIN;

ARTICLE; BREAST CANCER; BREAST DUCT; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONCOGENE C ERB; PREDICTION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0036997114     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00338     Document Type: Article

References (32)

1. Alford D, Taylor-Papadimitriou J (1996) Cell adhesion molecules in the normal and cancerous mammary gland. J Mammary Gland Biol Neoplasia 1: 207-218
2. Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G, Doglioni C (2001) p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 25: 1054-1060
3. Blaschuk OW, Farookhi R (1989) Estradiol stimulates cadherin expression in rat granulosa cells. Dev Biol 136: 564-567
4. Blaschuk OW, Munro SB, Farookhi R (1994) E-cadherin, estrogens and cancer: is there a connection? Can J Oncol 4: 291-301
5. Buerger H, Mommers EC, Littmann R, Simon R, Diallo R, Poremba C, Dockhorn-Dworniczak B, van Diest PJ, Boecker W (2001) Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 194: 165-170
6. Chen GT, Getsios S, MacCalman CD (1999) Cadherin-11 is a hormonally regulated cellular marker of decidualization in human endometrial stromal cells. Mol Reprod Dev 52: 158-165
7. Dairkee SH, Ljung BM, Smith H, Hackett A (1987) Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease. Breast Cancer Res Treat 10: 11-20
8. Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477
9. Daniel CW, Strickland P, Friedmann Y (1995) Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol 169: 511-519
10. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I- The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
11. Fujita M, Furukawa F, Fujii K, Horiguchi Y, Takeichi M, Imamura S (1992) Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and eccrine sweat ducts. Arch Dermatol Res 284: 159-166
12. Gamallo C, Moreno-Bueno G, Sarrio D, Calero F, Hardisson D, Palacios J (2001) The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod Pathol 14: 650-654
13. Han AC, Soler AP, Knudsen KA, Salazar H (1999) Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum Pathol 30: 1035-1039
14. Heinrich CA, Lail-Trecker MR, Peluso JJ, White BA (1999) Negative regulation of N-cadherin-mediated cell-cell adhesion by the estrogen receptor signalling pathway in rat pituitary GH3 cells. Endocrine 10: 67-76
15. Malzahn K, Mitze M, Thoenes M, Moll R (1998) Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch 433: 119-129
16. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR (2000) Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 60: 4346-4348
17. Nose A, Takeichi M (1986) A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 103: 2649-2658
18. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A, Gamallo C (1995) Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 146: 605-612
19. Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F (2002) P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch 440: 16-21
20. Peralta Soler A, Knudsen KA, Salazar H, Han AC, Keshgegian AA (1999) P-cadherin expression in breast carcinoma indicates poor survival. Cancer 86: 1263-1272
21. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumors. Nature 406: 747-752
22. Sahin AA (2000) Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer. Adv Anat Pathol 7: 158-166
23. Sannino P, Shousha S (1994) Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. J Clin Pathol 47: 90-92
24. Schmitt FC, Bento MJ, Amendoeira I (1995) Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: correlation with paraffin embedded and frozen sections determinations. Diagn Cytopathol 13: 347-351
25. Schmitt FC (1995) Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis. Eur J Cancer 31: 2049-2052
26. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M, Abe O (1989) Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 49: 2128-2133
27. Shimoyama Y, Hirohashi S (1991) Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 51: 2185-2192
28. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77: 2267-2274
29. Soler AP, Harner GD, Knudsen KA, McBrearty FX, Grujic E, Salazar H, Han AC, Keshgegian AA (1997) Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology. Am J Pathol 151: 471-478
30. Tsuda H, Takarabe T, Hasegawa F, Fukutomi T, Hirohashi (2000) Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 24: 197-202
31. Vienonen A, Syvala H, Miettinen S, Tuohimaa P, Ylikomi T (2002) Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines. J Steroid Biochem Mol Biol 80: 307-313
32. Wu JC, Gregory CW, De Philip RM (1993) P-cadherin and E-cadherin are co-expressed in MDCK cells. Biochem Biophys Res Commun 195: 1329-1335